Your browser doesn't support javascript.
loading
Salvianolic acid B, a new type I IRE1 kinase inhibitor, abrogates AngII-induced angiogenesis by interacting with IRE1 in its active conformation.
Fan, Fangtian; Liu, Fang; Shen, Peiliang; Tao, Li; Zhang, Hongjiang; Wu, Hongyan.
Afiliación
  • Fan F; Anhui Engineering Technology Research Center of Biochemical Pharmaceuticals, School of Pharmacy Bengbu Medical College, Bengbu, China.
  • Liu F; Anhui Engineering Technology Research Center of Biochemical Pharmaceuticals, School of Pharmacy Bengbu Medical College, Bengbu, China.
  • Shen P; School of Medicine & Holistic Integrative Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
  • Tao L; School of Medicine, Yangzhou University, Yangzhou, China.
  • Zhang H; Department of Pharmacology, Nanjing University of Chinese Medicine Hanlin College, Taizhou, China.
  • Wu H; Institute of Biomedical Technology, Jiangsu Vocational College of Medicine, Yancheng, China.
Clin Exp Pharmacol Physiol ; 50(1): 82-95, 2023 01.
Article en En | MEDLINE | ID: mdl-36153795

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Proteínas Quinasas / Neovascularización Patológica Idioma: En Revista: Clin Exp Pharmacol Physiol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Australia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inhibidores de Proteínas Quinasas / Neovascularización Patológica Idioma: En Revista: Clin Exp Pharmacol Physiol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Australia